An audit of acute myocardial infarction in a district general hospital: Results and recommendations

Journal of Clinical Excellence

Volumn 2, Issue 2, 2000, Pages 111-118

  Owen, A ^a   Husk, J ^a  

^a KENT AND CANTERBURY HOSPITAL   (United Kingdom)

Author keywords

ACE inhibitors; Aspirin; Audit; Beta blockers; Myocardial infarction; Thrombolysis

Indexed keywords

ACETYLSALICYLIC ACID; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRINOLYTIC AGENT; LISINOPRIL; STREPTOKINASE;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CLINICAL PRACTICE; CONTROLLED STUDY; DRUG UTILIZATION; FEMALE; FIBRINOLYSIS; GENERAL HOSPITAL; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL AUDIT; OUTCOMES RESEARCH; PROSPECTIVE STUDY;

EID: 0033708638     PISSN: 14659883     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction
2. A randomised trial of propranolol in patients with acute myocardial infarction
3. Effect on mortality of Metoprolol in acute myocardial infarction
4. Randomised trial of intravenous atenolol among 16027 cases of suspected acute myocardial infarction: ISIS-1
5. Randomised trial of intravenous streptokinase, oral aspirin, both or neither among 17187 cases of suspected myocardial infarction: ISIS-2
6. Secondary prevention of vascular disease by prolonged antiplatelet treatment
7. Collaborative Group indications for fibronolytic therapy in suspected acute myocardial infarction: Collaborative overview of early mortality and major morbidity results from all randomised trials or more than 1,000 patients
8. ISIS-3: A randomised comparison of streptokinase vs tissue plasminogen activator vs anistreplase and of aspirin plus heparin vs aspirin alone among 41299 cases of suspected acute myocardial infarction
9. GISSI-2: A factorial randomised trial of alteplase versus streptokinase and heparin versus no heparin among 12490 patients with acute myocardial infarction
10. An international randomised trial comparing four thrombolytic strategies for acute myocardial infarction
11. Thrombolysis after GUSTO: A European perspective
12. Large scale trials of thrombolytic therapy for acute myocardial infarction: GISSI-2, ISIS-3 and GUSTO-1
13. Effect of Ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure
14. Effect of Captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction
15. A clinical trial of the angiotensin converting enzyme inhibitor Trandolapril in patients with left ventricular dysfunction after myocardial infarction
16. Effects of Lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction
17. A randomised factorial trial assessing early oral Captopril, oral mononitrate, and intravenous magnesium sulphate in 58050 patients with suspected acute myocardial infarction
18. The effect of the angiotensin converting enzyme inhibitor Zofenopril on mortality and morbidity after myocardial infarction
19. Success of audit in reducing the time taken to administer thrombolysis and aspirin in patients with acute myocardial infarction
20. Increasing prescription of drugs for secondary prevention after myocardial infarction
21. An audit of discharge medication for secondary prophylaxis post myocardial infarction
22. The use of audit to set up a thrombolysis programme in the accident and emergency department
23. A British Cardiac Society survey of the potential for secondary prevention of coronary disease: ASPIRE (Action on Secondary Prevention through Intervention to Reduce Events)
24. Beta-blockers and antithrombolytic treatment for secondary prevention after acute myocardial infarction
25. Are both aspirin and heparin justified as adjuncts to thrombolytic therapy for acute myocardial infarction?
26. Intravenous beta blockade in acute myocardial infarction
27. Adverse outcomes of underuse of beta-blockers on elderly survivors of acute myocardial infarction